
Raymond J Henley Iii
Examiner (ID: 13341, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 1614, 1629, 1621, 2899 |
| Total Applications | 4270 |
| Issued Applications | 3011 |
| Pending Applications | 581 |
| Abandoned Applications | 704 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16769738
[patent_doc_number] => 10980821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Triphenylphosphonium-derivative compounds for eradicating cancer stem cells
[patent_app_type] => utility
[patent_app_number] => 16/766472
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 5917
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766472 | Triphenylphosphonium-derivative compounds for eradicating cancer stem cells | Nov 20, 2018 | Issued |
Array
(
[id] => 16482351
[patent_doc_number] => 20200375951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => DANTROLENE AND ANALOGS THEREOF FOR THE CHRONIC TREATMENT AND PREVENTION OF DYSSYNCHRONOUS CARDIAC DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/763914
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763914 | Dantrolene and analogs thereof for the chronic treatment and prevention of dyssynchronous cardiac dysfunction | Nov 13, 2018 | Issued |
Array
(
[id] => 14435465
[patent_doc_number] => 20190175604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => EZH2 INHIBITORS FOR TREATING LYMPHOMA
[patent_app_type] => utility
[patent_app_number] => 16/181747
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/181747 | EZH2 INHIBITORS FOR TREATING LYMPHOMA | Nov 5, 2018 | Abandoned |
Array
(
[id] => 16420504
[patent_doc_number] => 20200345702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => METHOD FOR TREATING THALASSEMIA
[patent_app_type] => utility
[patent_app_number] => 16/758986
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758986 | Method for treating thalassemia | Oct 25, 2018 | Issued |
Array
(
[id] => 14833185
[patent_doc_number] => 20190274993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => GLUTAMINASE INHIBITOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/164581
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/164581 | Glutaminase inhibitor therapy | Oct 17, 2018 | Issued |
Array
(
[id] => 17923019
[patent_doc_number] => 11466254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation
[patent_app_type] => utility
[patent_app_number] => 16/757335
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12000
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757335
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757335 | Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation | Oct 15, 2018 | Issued |
Array
(
[id] => 16204753
[patent_doc_number] => 20200237743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => CRAC CHANNEL MODULATORS FOR TREATING ESOPHAGEAL CANCER
[patent_app_type] => utility
[patent_app_number] => 16/756077
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756077
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756077 | CRAC CHANNEL MODULATORS FOR TREATING ESOPHAGEAL CANCER | Oct 15, 2018 | Abandoned |
Array
(
[id] => 16930777
[patent_doc_number] => 20210196666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => Compounds For Inhibiting Secretory Leukocyte Protease Inhibitor (SLPI)
[patent_app_type] => utility
[patent_app_number] => 16/754912
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754912 | Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI) | Oct 8, 2018 | Issued |
Array
(
[id] => 14712593
[patent_doc_number] => 20190247360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => Pharmaceutical Composition for Treating Bacterial and Viral infections
[patent_app_type] => utility
[patent_app_number] => 16/153589
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153589 | Pharmaceutical Composition for Treating Bacterial and Viral infections | Oct 4, 2018 | Abandoned |
Array
(
[id] => 16341586
[patent_doc_number] => 20200306236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => COMBINATION THERAPIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/754083
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754083 | Combination therapies and uses thereof | Oct 4, 2018 | Issued |
Array
(
[id] => 14403709
[patent_doc_number] => 20190167698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Methods of Treating Certain Depressive Disorders and Delirium Tremens
[patent_app_type] => utility
[patent_app_number] => 16/150782
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150782 | Methods of treating certain depressive disorders and delirium tremens | Oct 2, 2018 | Issued |
Array
(
[id] => 14712521
[patent_doc_number] => 20190247324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy
[patent_app_type] => utility
[patent_app_number] => 16/149983
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16149983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/149983 | One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy | Oct 1, 2018 | Abandoned |
Array
(
[id] => 13867295
[patent_doc_number] => 20190029988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => EXTENDED DURATION LOCAL ANESTHETIC FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/148080
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148080 | Extended duration local anesthetic formulation | Sep 30, 2018 | Issued |
Array
(
[id] => 16236683
[patent_doc_number] => 20200253917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/651835
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651835 | COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH | Sep 27, 2018 | Abandoned |
Array
(
[id] => 16612086
[patent_doc_number] => 20210030739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/649277
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649277 | Compositions and methods of treating cancer | Sep 27, 2018 | Issued |
Array
(
[id] => 17602850
[patent_doc_number] => 11331319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Combination treatment for neuropsychiatric disorders
[patent_app_type] => utility
[patent_app_number] => 16/651001
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19607
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651001
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651001 | Combination treatment for neuropsychiatric disorders | Sep 26, 2018 | Issued |
Array
(
[id] => 18188571
[patent_doc_number] => 11579147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Use of VNN1 as a biomarker and a therapeutic target in sarcomas
[patent_app_type] => utility
[patent_app_number] => 16/649860
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11175
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649860 | Use of VNN1 as a biomarker and a therapeutic target in sarcomas | Sep 24, 2018 | Issued |
Array
(
[id] => 15571391
[patent_doc_number] => 10576053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
[patent_app_type] => utility
[patent_app_number] => 16/134140
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14225
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16134140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/134140 | Composition containing eicosapentaenoic acid alkyl ester, and method for producing same | Sep 17, 2018 | Issued |
Array
(
[id] => 14594025
[patent_doc_number] => 10350187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin
[patent_app_type] => utility
[patent_app_number] => 16/133793
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 5181
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133793 | Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin | Sep 17, 2018 | Issued |
Array
(
[id] => 14743821
[patent_doc_number] => 20190255084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/133322
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133322 | Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof | Sep 16, 2018 | Issued |